Pharma faces payment disclosure law

Senator Charles Grassley said he would, and now he has: The Republican introduced a bill Thursday that would require drug and medical device makers to report almost every cent they pay to doctors. Each payment of more than $25 would have to be disclosed quarterly, and the data would be posted on a government website.

For several months now, news reports and Congressional hearings have been questioning the flow of dollars from drug makers to doctors--everything from free meals to speaking fees to consulting payments. Some doctors have reaped hundreds of thousands a year in such gifts or fees-for-services. The natural follow-up question--does it change doctors' behavior when they pick up their prescription pads?--has prompted much defensive denial, but it's also inspired fears of unnecessarily costly scrips and even patient harm.

Anticipating the outcry from pharma, Sen. Herb Kohl, the bill's co-sponsor, said that if companies have nothing to hide, then disclosure will only vindicate them. "Either way, patients win," he said.

- check out the release
- read the New York Times article

ALSO: Should drug and medical device makers be made to to report payments made to doctors? Poll

Related Articles:
Law would make pharmas reveal MD payments. Report
Psychiatrists getting largest pharma gifts. Report
NY bill would require pharmas to report MD gifts. Report
Doctors weigh in on pros, cons of accepting freebies. Letters
States tighten screws on pharma marketers. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.